|
Acute nervous system disorder (disorder)
|
127341005 |
|
|
Suspected fetal damage from disease in the mother (situation)
|
609420007 |
|
|
Suspected fetal disorder (situation)
|
609415007 |
|
|
Product containing precisely dantrolene sodium 50 milligram/1 each conventional release oral capsule (clinical drug)
|
374690009 |
|
|
Transcleral approach (qualifier value)
|
260635009 |
|
|
Ocular approaches (qualifier value)
|
311802005 |
|
|
Family history of localized scleroderma (situation)
|
1264398004 |
|
|
Potassium supplement (substance)
|
387421008 |
|
|
Mineral supplement (substance)
|
373460003 |
|
|
Potassium compound (substance)
|
19751002 |
|
|
Requires a tetanus booster (finding)
|
170537006 |
|
|
Requires vaccination (finding)
|
723620004 |
|
|
Pulse volume - full (finding)
|
421014001 |
|
|
Finding of pulse volume (finding)
|
366201008 |
|
|
Corydalis (organism)
|
67096007 |
|
|
Family Papaveraceae - poppy (organism)
|
107535007 |
|
|
Product containing precisely danazol 100 milligram/1 each conventional release oral capsule (clinical drug)
|
326021001 |
|
|
Product containing precisely sodium chloride 20 milligram/1 milliliter conventional release eye solution (clinical drug)
|
437830007 |
|
|
Mouse toxin neutralization test (procedure)
|
34146008 |
|
|
Immunology laboratory test (procedure)
|
252318005 |
|
